What percentage of APOE4 homozygotes show amyloid protein by 65?

Question

Accepted Answer

At Least 95 Percent of APOE4 Homozygotes Exhibit Amyloid Protein by Age 65

Research indicates that individuals carrying two copies of the APOE4 gene variant, known as homozygotes, are highly likely to develop Alzheimer's disease, with a significant majority exhibiting biomarkers of the disease by age 65. Specifically, at least 95 percent of these individuals show abnormal levels of beta-amyloid protein in their spinal fluid by this age. Furthermore, brain scans for amyloid are positive in 75 percent of APOE4 homozygotes by the time they reach 65.
Amyloid Accumulation in APOE4 Homozygotes

The study observed that nearly all APOE4 homozygotes in the analysed cohorts presented with higher amyloid levels at age 65 compared to individuals without this specific gene variant. This consistent pattern of amyloid accumulation suggests that APOE4 homozygotes are meeting key criteria indicative of a genetic form of Alzheimer's disease, including the presence of Alzheimer's biology, a similar rate of symptom development, and a predictable sequence of biological changes.
Implications for Alzheimer's Research and Treatment

These findings could significantly impact the approach to Alzheimer's research and treatment. The high prevalence of amyloid pathology in APOE4 homozygotes by age 65 suggests that interventions targeting amyloid, such as the recently approved drug Leqembi, might be considered for this group at younger ages. However, it is noted that patients with two copies of the APOE4 variant have shown higher rates of brain bleeding and swelling in clinical trials associated with such treatments.
Redefining Genetic Alzheimer's Disease

The research proposes that individuals with two copies of the APOE4 gene may represent a distinct genetic form of Alzheimer's disease, rather than merely a risk factor. This reclassification could lead to changes in how Alzheimer's research is conducted, how diagnoses are made, and how treatment strategies are developed for this specific genetic profile. The findings also underscore the importance of enrolling APOE4 homozygotes into preventative trials before symptoms manifest.

Reading history

Hide →

This history is cleared when the page is closed.

What percentage of APOE4 homozygotes show amyloid protein by 65?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends